https://wiki.tradeville.ro/index.php?action=history&feed=atom&title=Immunocore_Holdings_plcImmunocore Holdings plc - Revizia istoricului2026-04-04T05:16:55ZIstoricul versiunilor pentru această pagină din wikiMediaWiki 1.39.2https://wiki.tradeville.ro/index.php?title=Immunocore_Holdings_plc&diff=425129&oldid=prevAdmin: Pagină nouă: Pagina dedicata companiei Immunocore Holdings plc listata cu simbolul US.IMCR ==Descriere companie== Immunocore Holdings plc, formerly Immunocore Holdings Ltd, (http://www.immunocore.com/) is a late-stage biotechnology company. The Company is engaged in the development of TCR bispecific immunotherapies called Immune mobilizing monoclonal TCRs Against X disease (ImmTAX) designed to treat diseases, including cancer, infectious and autoimmune. The Company is developing a deep p...2024-09-18T18:04:27Z<p>Pagină nouă: Pagina dedicata companiei Immunocore Holdings plc listata cu simbolul US.IMCR ==Descriere companie== Immunocore Holdings plc, formerly Immunocore Holdings Ltd, (http://www.immunocore.com/) is a late-stage biotechnology company. The Company is engaged in the development of TCR bispecific immunotherapies called Immune mobilizing monoclonal TCRs Against X disease (ImmTAX) designed to treat diseases, including cancer, infectious and autoimmune. The Company is developing a deep p...</p>
<p><b>Pagină nouă</b></p><div>Pagina dedicata companiei Immunocore Holdings plc listata cu simbolul US.IMCR<br />
<br />
==Descriere companie==<br />
Immunocore Holdings plc, formerly Immunocore Holdings Ltd, (http://www.immunocore.com/) is a late-stage biotechnology company. The Company is engaged in the development of TCR bispecific immunotherapies called Immune mobilizing monoclonal TCRs Against X disease (ImmTAX) designed to treat diseases, including cancer, infectious and autoimmune. The Company is developing a deep pipeline in multiple therapeutic areas, including five clinical stage programs in oncology and infectious disease, advanced pre-clinical programs in autoimmune disease and multiple earlier pre-clinical programs. The Company’s pipeline is leveraging ImmTAX platform within three therapeutic areas: oncology, infectious disease and autoimmune disease.<br />
<br />
==Grafic actiuni companie==<br />
<iframe key="tradeville" path="graficSimbol/US.IMCR" /><br />
<br />
==Ultimele stiri despre Immunocore Holdings plc (US.IMCR)==<br />
<dynamicpagelist><br />
category=US.IMCR<br />
count=10<br />
order=descending<br />
addfirstcategorydate=false<br />
</dynamicpagelist><br />
<br />
[[Categorie:US.IMCR]][[Categorie:Stiri despre companii]]</div>Admin